10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2023-11-14 (Q3 2023) | Holdings: 65 | Value: $5.0B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | Reduce 5% $(47.4M) | 19.91% | $1.0B | +88.16% | +56.00% | +34.07% | |
| LEGN - LEGEND BIOTECH CORP-ADR | 8.35% | $420.8M | -51.98% | -12.98% | -41.75% | ||
| PCVX - VAXCYTE INC | 7.98% | $402.3M | -28.99% | +53.05% | +77.17% | ||
| IMGN - IMMUNOGEN INC | Add 472% ($174.4M) | 4.19% | $211.4M | ||||
| ETNB - 89BIO INC | 3.50% | $176.3M | +30.54% | +28.31% | +3.93% | ||
| BIIB - BIOGEN INC | 2.72% | $137.0M | -41.92% | -0.48% | -28.71% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | 2.58% | $130.1M | +103.26% | +55.01% | +72.70% | ||
| AVTE - AEROVATE THERAPEUTICS INC | 2.22% | $112.1M | +49.86% | -82.48% | |||
| CBAY - CYMABAY THERAPEUTICS INC | New Purchase | 2.05% | $103.5M | +87.43% | |||
| VRNA - VERONA PHARMA PLC - ADR | 2.04% | $103.0M | +464.99% | +10.63% | +135.54% | ||
| TYRA - TYRA BIOSCIENCES INC | 1.98% | $99.6M | -17.32% | +54.47% | +25.12% | ||
| WVE - WAVE LIFE SCIENCES LTD | 1.96% | $98.9M | +23.18% | -31.20% | +149.45% | ||
| GERN - GERON CORP | Add 46% ($31.1M) | 1.94% | $97.9M | -18.75% | +8.85% | +90.63% | |
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 1.90% | $95.8M | -42.66% | +26.73% | +9.82% | ||
| JANX - JANUX THERAPEUTICS INC | Add 6% ($5.0M) | 1.83% | $92.4M | +193.02% | +12.43% | +477.04% | |
| ANTX - AN2 THERAPEUTICS INC | Add 47% ($28.6M) | 1.77% | $89.3M | -93.07% | -75.97% | -93.76% | |
| INBX - INHIBRX INC | Add 23% ($16.0M) | 1.72% | $86.7M | ||||
| RXST - RXSIGHT INC | 1.69% | $85.1M | -44.64% | +98.70% | +67.16% | ||
| NAMS - NEWAMSTERDAM PHARMA CO NV | 1.65% | $83.3M | +107.77% | +109.48% | +165.18% | ||
| EVH - EVOLENT HEALTH INC - A | New Purchase | 1.48% | $74.5M | -72.50% | +4.94% | -58.43% | |
| CVAC - CUREVAC NV | Reduce 13% $(11.2M) | 1.44% | $72.4M | -21.34% | -38.98% | -55.20% | |
| AXSM - AXSOME THERAPEUTICS INC | 1.39% | $69.9M | +76.35% | +48.94% | +48.48% | ||
| COGT - COGENT BIOSCIENCES INC | 1.24% | $62.6M | -16.57% | +23.68% | +23.96% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | Add 53% ($21.4M) | 1.23% | $62.0M | -50.23% | +45.58% | +11.63% | |
| TSHA - TAYSHA GENE THERAPIES INC | New Purchase | 1.16% | $58.4M | +92.00% | +6.00% | +37.33% | |
| GHRS - GH RESEARCH PLC | 1.11% | $56.2M | +65.70% | +5.12% | +19.45% | ||
| ALPN - ALPINE IMMUNE SCIENCES INC | 1.07% | $53.7M | +134.35% | ||||
| FDMT - 4D MOLECULAR THERAPEUTICS IN | Add 36% ($13.9M) | 1.05% | $53.0M | -64.49% | +151.50% | -19.80% | |
| FULC - FULCRUM THERAPEUTICS INC | 1.02% | $51.5M | +81.38% | +139.80% | -23.34% | ||
| ITOS - ITEOS THERAPEUTICS INC | 0.96% | $48.4M | +2.62% | +1.51% | -17.04% | ||
| VOR - VOR BIOPHARMA INC | 0.96% | $48.2M | -88.41% | +9.84% | -55.24% | ||
| ICVX - ICOSAVAX INC | 0.92% | $46.2M | +77.59% | ||||
| ACRV - ACRIVON THERAPEUTICS INC | 0.91% | $46.0M | -75.00% | -20.00% | +39.20% | ||
| APGE - APOGEE THERAPEUTICS INC | New Purchase | 0.84% | $42.1M | +116.26% | +105.28% | +171.40% | |
| PEPG - PEPGEN INC | 0.82% | $41.3M | -65.87% | +239.18% | -0.96% | ||
| RNA - AVIDITY BIOSCIENCES INC | 0.81% | $40.9M | +474.96% | +118.58% | +581.42% | ||
| SLNO - SOLENO THERAPEUTICS INC | New Purchase | 0.73% | $36.6M | +245.84% | +113.66% | +138.16% | |
| SPRY - ARS PHARMACEUTICALS INC | Add 214% ($24.4M) | 0.71% | $35.8M | +214.75% | +70.02% | +228.10% | |
| ELYM - ELIEM THERAPEUTICS INC | 0.69% | $34.6M | -51.66% | +3.31% | +17.35% | ||
| VRDN - VIRIDIAN THERAPEUTICS INC | 0.61% | $30.8M | -5.07% | +28.20% | +34.27% | ||
| PLRX - PLIANT THERAPEUTICS INC | 0.61% | $30.6M | -87.84% | +26.89% | -6.12% | ||
| MLYS - MINERALYS THERAPEUTICS INC | 0.60% | $30.2M | +117.25% | +108.34% | +59.67% | ||
| ACRS - ACLARIS THERAPEUTICS INC | 0.60% | $30.1M | +129.78% | +81.18% | +201.96% | ||
| MDGL - MADRIGAL PHARMACEUTICALS INC | New Purchase | 0.59% | $29.9M | +75.18% | +42.02% | +84.43% | |
| ELVN - ENLIVEN THERAPEUTICS INC | 0.58% | $29.0M | +92.18% | +55.58% | +119.51% | ||
| EYPT - EYEPOINT PHARMACEUTICALS INC | 0.53% | $26.9M | +28.11% | +351.55% | +42.39% | ||
| URGN - UROGEN PHARMA LTD | New Purchase | 0.41% | $20.8M | -55.50% | +62.77% | -3.12% | |
| TNYA - TENAYA THERAPEUTICS INC | Add 11% ($1.7M) | 0.34% | $17.1M | -71.88% | +201.04% | +2.60% | |
| BCYC - BICYCLE THERAPEUTICS PLC-ADR | New Purchase | 0.32% | $16.1M | -42.18% | +50.27% | +48.23% | |
| HOWL - WEREWOLF THERAPEUTICS INC | 0.26% | $13.2M | -44.34% | +185.07% | -19.91% | ||
| BDTX - BLACK DIAMOND THERAPEUTICS I | Reduce 100% | 0.00% | $0.00 | ||||
| CELC - CELCUITY INC | Reduce 100% | 0.00% | $0.00 | ||||
| CTKB - CYTEK BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| DICE - DICE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| DSGN - DESIGN THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| IGMS - IGM BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| NKTX - NKARTA INC | Reduce 100% | 0.00% | $0.00 | ||||
| SLDB - SOLID BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||